使用小肠和大肠单层界面的牛类器官技术的进步
June 14th, 2024
本研究提出了一种从类器官生成牛肠道 2D 单层的方案，为研究宿主-病原体相互作用提供了更好的途径。它包括评估膜完整性和功能的方法，推进模拟牛胃肠道生理学的 体外 模型。这种方法有望带来显著的生物医学和农业效益，包括增强的治疗策略。
我们的研究目标是建立强大的技术来生成源自成年牛小肠和大肠类器官的主要肠道单层界面。我们采用多模态分析方法来确认已建立的单层内功能性上皮屏障的形成。与三维模型不同，2D 单层提供了一个暴露的、可接近的管腔表面，这对于研究宿主病原体相互作用至关重要。
这些反映具有多个细胞谱系的体内肠道的单层细胞现在为研究特定肠道切片（如小肠壁龛和大肠壁龛）中的病原体提供了量身定制的方案。我们的研究确定了优化的培养条件，以从牛商场和大肠类器官的细胞中创建和维持 2D 单层。我们使用跨上皮电登记剂和细胞旁通透性测定以及免疫细胞化学染色技术证实了这些单层内功能性上皮屏障的形成。
我们的方案通过关注缺乏肠道类器官衍生的牛单层模型来解决研究空白。这些模型已在小鼠和人类中进行了充分研究，但是，牛是具有严重公共卫生影响的肠道病原体的主要宿主，尚未得到充分探索。我们的研究建立并表征了 2D 牛单层培养系统。
这种创新工具允许探索牛肠道生理学的正常和疾病状态，其潜在应用可扩展到具有公共卫生意义的生物医学和转化研究。
概览
本研究提出了一种从小牛肠道类器官生成二维单层的协议，有助于研究宿主-病原体的相互作用。该方法包括评估膜完整性和功能的方法，推进模拟牛的胃肠生理学的体外模型。
研究的主要组成部分
科学领域
- 神经科学
- 生物学
- 生物医学研究
背景
- 肠道类器官衍生的单层在小鼠和人类中已经得到了很好的研究。
- 牛是肠道病原体的主要储存库，对公共卫生有严重影响。
- 现有的模型缺乏对牛肠道生理学的充分探索。
- 二维单层为研究宿主-病原体相互作用提供了可接触的表面。
研究目的
- 建立从类器官生成牛肠道单层的技术。
- 创建反映体内肠道环境的模型。
- 优化维持二维单层的培养条件。
所用方法
- 用细胞外基质涂覆细胞培养插入物。
- 孵育类器官衍生的细胞以形成单层。
- 使用跨上皮电阻和通透性测定来评估屏障功能。
- 采用免疫细胞化学用于细胞表征。
主要结果
- 在二维单层中成功形成功能性上皮屏障。
- 确定牛肠道细胞的优化培养条件。
- 通过扫描电子显微镜确认微绒毛和细胞界限的存在。
- 免疫荧光染色揭示了单层中的关键细胞结构。
结论
- 开发的二维单层培养系统是研究牛肠道生理学的重大进展。
- 该模型在生物医学和转化研究中具有潜在应用。
- 它解决了理解牛肠道健康和疾病的关键研究空白。
常见问题
Executive Industry Relevance
Establishing robust 2D monolayer interfaces from bovine intestinal organoids addresses a critical gap in translational models for host-pathogen interaction studies. This advancement enables predictive, species-specific interrogation of gastrointestinal barrier function, supporting early discovery and mechanistic de-risking in both animal health and food safety pipelines. The approach enhances portfolio confidence by providing physiologically relevant, reproducible in vitro systems for disease modeling and intervention assessment.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables functional validation of epithelial barrier integrity using quantitative transepithelial resistance and permeability assays.
- Supports mechanistic de-risking by modeling host-pathogen interactions in disease-relevant bovine intestinal niches.
- Facilitates hypothesis-driven exploration of cellular lineage contributions to barrier function.
Screening & Assay Development
- Provides a standardized, reproducible platform for quantitative assessment of compound effects on epithelial integrity.
- Delivers accessible luminal surfaces for direct exposure studies and high-content screening.
- Enables immunocytochemical characterization to confirm assay system fidelity and reproducibility.
Translational & Preclinical Research
- Aligns in vitro findings with in vivo bovine physiology for translational biomarker development.
- Supports continuity from discovery through preclinical validation in food safety and animal health research.
- Reduces translational risk by modeling both normal and diseased intestinal states in a species-relevant context.
Pipeline & Workflow Integration
This 2D monolayer system integrates into the discovery-to-preclinical continuum, bridging early mechanistic studies and translational validation for bovine gastrointestinal research.
- Discovery Biology: Enables hypothesis testing of barrier function and host-pathogen mechanisms in a controlled, quantitative system.
- Screening: Provides assay-ready, reproducible monolayers for compound evaluation and mechanistic screening.
- Analytics: Delivers quantitative outputs such as transepithelial resistance and permeability for comparative analysis.
- Translational Research: Facilitates alignment of in vitro results with in vivo disease models and biomarker strategies.
- Enterprise Reuse: Establishes a reusable, scalable platform for ongoing R&D in bovine intestinal health and pathogen studies.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in gastrointestinal research.
- Operational Value: Standardizes protocols for reproducibility and scalability across research teams.
- Strategic Value: Improves go/no-go decision-making and capital efficiency by enabling early de-risking.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of animal health and food safety programs.
Implementation Considerations
- Requires expertise in organoid culture, epithelial biology, and quantitative barrier assays.
- Needs access to cell culture infrastructure, microplate readers, and immunocytochemistry capabilities.
- Demands cross-team standardization for protocol reproducibility and data comparability.
- Adaptation may be needed for different intestinal regions or pathogen models.
- Limitations include species specificity and the need for ongoing validation against in vivo benchmarks.
